Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
The outer capsid proteins VP4 and VP7 induce neutralizing antibody against rotavirus. We have investigated in a mouse model the protection mediated by immunization with VP8*, the amino-terminal tryptic fragment of VP4. BALB/c female mice immunized with simian rotavirus SA11 VP6 and VP8* proteins expressed in Escherichia coli were mated with seronegative males. Litters were orally challenged with the SA11 strain (P5B[2], G3) or with the murine rotavirus strain EDIM (P10[16], G3) to verify the degree of protection against diarrhea induced in the newborns. Only those pups born to dams immunized with VP8* did not develop diarrhea after having been orally challenged with the SA11 strain. Pups born to naive dams but foster nursed by VP8*-immunized dams did not develop diarrhea after having been orally infected with the SA11 strain, but they suffered diarrhea when challenged with the EDIM strain. These results support the concepts that (1) VP8* is a highly immunogenic polypeptide that induces effective homotypic protection against disease in pups born to dams immunized with this antigen and (2) in newborn mice the protection against disease is mediated by neutralizing secretory antibodies present in the milk rather than by serum antibodies transferred through the placenta to the offspring.
Gil
M T
MT
Department of Microbiology, Hospital Clinico Universitario, Facultad de Medicina, Universidad de Valencia, Spain.
de Souza
C O
CO
Asensi
M
M
Buesa
J
J
D000818:Animals; D000831:Animals, Newborn / Q000276:immunology; D000914:Antibodies, Viral / Q000097:blood; D000956:Antigens, Viral; D001942:Breast Feeding; D002213:Capsid / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D036022:Capsid Proteins; D003967:Diarrhea / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism; D005260:Female; D005982:Glutathione Transferase / Q000235:genetics / Q000378:metabolism; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D051379:Mice; D008807:Mice, Inbred BALB C; D008892:Milk / Q000276:immunology; D009500:Neutralization Tests; D016601:RNA-Binding Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000276:immunology; D012401:Rotavirus / Q000276:immunology; D012400:Rotavirus Infections / Q000276:immunology* / Q000517:prevention & control; D022243:Rotavirus Vaccines / Q000008:administration & dosage / Q000276:immunology*; D014611:Vaccination; D022223:Vaccines, Subunit / Q000276:immunology; D017361:Viral Nonstructural Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D036022:Capsid Proteins; D016601:RNA-Binding Proteins; D011993:Recombinant Fusion Proteins; D022243:Rotavirus Vaccines; C060339:VP4 protein, Rotavirus; C061332:VP6 protein, Rotavirus; D022223:Vaccines, Subunit; D017361:Viral Nonstructural Proteins; C079234:NS35 protein, rotavirus; D005982:Glutathione Transferase